Cholinergic innervation of the guinea-pig isolated vas deferens

被引:0
作者
Pravesh Solanki
Alina M. Cuprian-Beltechi
Thomas C. Cunnane
机构
[1] University of Oxford,Department of Pharmacology
来源
Naunyn-Schmiedeberg's Archives of Pharmacology | 2007年 / 376卷
关键词
Guinea-pig vas deferens; Cholinergic innervation; Neostigmine; Bretylium; Muscarinic receptor subtypes; Ca; transients; Confocal microscopy;
D O I
暂无
中图分类号
学科分类号
摘要
Recently, a cholinergic neurogenic component of contraction has been characterised in the aganglionic mouse vas deferens. In this paper, a cholinergic component of contraction in the guinea-pig vas deferens is characterised pharmacologically. A residual, tetrodotoxin-sensitive (TTX, 0.3 μM), neurogenic contraction was revealed after prolonged exposure (5 h) to the adrenergic neurone blocker bretylium (20 μM) or in the presence of prazosin (100 nM) and α,β-methylene ATP (1 μM), a purinergic agonist which desensitizes P2X receptors. The bretylium-resistant component was potentiated by the acetylcholinesterase (AChE) inhibitor neostigmine (10 μM) and inhibited by the muscarinic-receptor (mAChR) antagonist cyclopentolate (1 μM). Nicotine (30 μM) enhanced the bretylium-resistant component. Neostigmine increased the second component of contraction in the presence of prazosin and α,β-methylene ATP, whilst yohimbine (1 μM), an α2 adrenergic receptor antagonist, enhanced both the first and second components of the electrically evoked contraction. These enhanced contractions were blocked by cyclopentolate in both cases. Nicotine enhanced the cholinergic component of contraction revealed by neostigmine but failed to have any detectable effects in the presence of cyclopentolate. Neostigmine alone increased the slow component of contraction which was reversed by cyclopentolate to control levels. The M3 receptor-antagonist 4-DAMP (10 nM) markedly inhibited the cholinergic component of contraction to a level comparable with cyclopentolate. Laser microscopy has shown that neostigmine also increased the frequency of spontaneous Ca2+ transients remaining in smooth muscle cells after perfusion with prazosin and α,β-methylene ATP, an effect blocked by 4-DAMP. These experimental data show that there is a functional cholinergic innervation in the guinea-pig vas deferens whose action is limited by acetylcholinesterase, blocked by cyclopentolate and mediated through M3 receptors. Moreover, by blocking the cholinesterase, the increased amount of ACh generates spontaneous Ca2+ transients in smooth muscle cells.
引用
收藏
页码:265 / 274
页数:9
相关论文
共 126 条
  • [1] Aberdeen J(1990)Marked increases in calcitonin gene-related peptide-containing nerves in the developing rat following long-term sympathectomy with guanethidine Neuroscience 35 175-184
  • [2] Corr L(1967)An electrophysiological study of the effects of atropine and physostigmine on transmission to the guinea-pig vas deferens J Physiol 189 31-42
  • [3] Milner P(1967)Localization of norepinephrine and acetylcholinesterase in separate neurons supplying the guinea-pig vas deferens J Pharmacol Exp Ther 157 69-73
  • [4] Lincoln J(1966)The effect of local anaesthetic and anti-adrenaline drugs on the response of sympathetically innervated smooth muscle preparations to electrical stimulation at different frequencies Br J Pharmac Chemother 27 64-80
  • [5] Burnstock G(1965)Independent cholinergic and adrenergic mechanisms in the guinea-pig isolated nerve vas deferens preparation B J Pharmcol 24 641-650
  • [6] Bell C(2006)Calcium events in smooth muscles and their interstitial cells; physiological roles of sparks J Physiol 570 5-11
  • [7] Bell C(2001)Nicotine induces calcium spikes in single nerve terminal varicosities: a role for intracellular calcium stores Neuroscience 106 395-403
  • [8] McLean JR(2002)Intermittent ATP release from nerve terminals elicits focal smooth muscle Ca J Physiol 541 849-862
  • [9] Bentley GA(1993) transients in mouse vas deferens Biol Signals 2 199-206
  • [10] Bhargava KP(1969)Presynaptic modulation by melatonin of the nicotinic-induced calcium-dependent release of norepinephrine from the rat vas deferens Int J Neuropharmacol 8 399-403